Qidni Labs key facts
as of Oct 2026- Developer of dialysis technologies and devices designed to make dialysis accessible and sustainable for patients with kidney failure worldwide.
- Qidni Labs is valued at approximately $22.5M as of Oct 2026 (last reported valuation).
- It has raised $8.5M; the latest was Later Stage VC ($5.0M) in Aug 2025.
- Notable investors include SOSV, Endless Frontier Labs, IndieBio, MaRS Discovery District, Neman Ventures — 25 tracked in total.
- Status: Privately Held (backing).
Qidni Labs's last reported valuation, Aug 2025. Nothing priced has surfaced since.
- ·The complete investor list: 25 names
- ·Watch Qidni Labs: the Monday email on marks, rounds and moves
Qidni Labs funding rounds
No funding rounds for Qidni Labs are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Qidni Labs
25+Qidni Labs valuation
Qidni Labs's last reported valuation was $22.5 million in Aug 2025. No priced round, secondary trade or fund mark has surfaced since.
Qidni Labs investors
25 investors are on record for Qidni Labs, including SOSV, Endless Frontier Labs, IndieBio and MaRS Discovery District.
About Qidni Labs
Developer of dialysis technologies and devices designed to make dialysis accessible and sustainable for patients with kidney failure worldwide. The company offers a portable dialysis system that is nearly waterless and battery-powered with cloud-based remote monitoring of treatment and helps remove uremic toxins and other solutes from large volumes of whole blood, enabling patients to remove all barriers in the way patients access treatment.
- Sector
- Healthcare
- HQ
- Buffalo, NY, United States
- Founded
- 2014
- Employees
- 9
- Website
- qidni.life/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.